{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:06:57Z","timestamp":1791979617612,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["G00004202"],"award-info":[{"award-number":["G00004202"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["G00003430"],"award-info":[{"award-number":["G00003430"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jiph.2023.11.003","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T14:39:45Z","timestamp":1699367985000},"page":"33-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S1","title":["High efficacy and enhanced synergistic activity of the novel siderophore-cephalosporin cefiderocol against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae from inpatients attending a single hospital in the United Arab Emirates"],"prefix":"10.1016","volume":"16","author":[{"given":"Lana","family":"Daoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Al-Marzooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akela","family":"Ghazawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Febin","family":"Anes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Collyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2023.11.003_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2023.11.003_bib2","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.drudis.2019.08.004","article-title":"Superbugs but no drugs: steps in averting a post-antibiotic era","volume":"24","author":"Hamad","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jiph.2023.11.003_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/MMBR.00078-15","article-title":"Klebsiella pneumoniae: going on the offense with a strong defense","volume":"80","author":"Paczosa","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.jiph.2023.11.003_bib4","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/AAC.03098-15","article-title":"Stability of novel siderophore cephalosporin S-649266 against clinically relevant carbapenemases","volume":"60","author":"Ito-Horiyama","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s40121-023-00773-6","article-title":"Cefiderocol, a siderophore cephalosporin, as a treatment option for infections caused by carbapenem-resistant Enterobacterales","volume":"12","author":"Kaye","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jiph.2023.11.003_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"van Duin","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.jiph.2023.11.003_bib7","article-title":"In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria","volume":"62","author":"Ito","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib8","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/antibiotics11070904","article-title":"Cefiderocol for carbapenem-resistant bacteria: handle with care! a review of the real-world evidence","volume":"11","author":"Sansone","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.jiph.2023.11.003_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02011-21","article-title":"New Delhi metallo-beta-lactamase facilitates the emergence of cefiderocol resistance in Enterobacter cloacae","volume":"66","author":"Nurjadi","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/cid\/ciab888","article-title":"Progressive development of cefiderocol resistance in Escherichia coli during therapy is associated with an increase in blaNDM-5 copy number and gene expression","volume":"75","author":"Simner","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2023.11.003_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.741940","article-title":"Cefiderocol: an overview of its in-vitro and in-vivo activity and underlying resistant mechanisms","volume":"8","author":"Yao","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jiph.2023.11.003_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01582-20","article-title":"In vitro activity of cefiderocol, a siderophore cephalosporin, against multidrug-resistant Gram-negative bacteria","volume":"64","author":"Mushtaq","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jgar.2020.07.009","article-title":"Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)","volume":"22","author":"Kohira","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiph.2023.11.003_bib14","article-title":"Cefiderocol resistance in Klebsiella pneumoniae is linked to SHV extended-spectrum \u03b2-lactamase activities and functional loss of the outer membrane porin OmpK35","volume":"0","author":"Moon","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiph.2023.11.003_bib15","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1021\/acs.jmedchem.9b01279","article-title":"\u03b2-lactamase inhibitors to restore the efficacy of antibiotics against superbugs","volume":"63","author":"Gonz\u00e1lez-Bello","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.jiph.2023.11.003_bib16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cmi.2017.09.001","article-title":"New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn","volume":"23","author":"Wright","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiph.2023.11.003_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1060736","article-title":"Biochemical exploration of \u03b2-lactamase inhibitors","volume":"13","author":"Arer","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.jiph.2023.11.003_bib18","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.43.2200795","article-title":"Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022","volume":"27","author":"Coppi","year":"2022","journal-title":"Eur Surveill"},{"key":"10.1016\/j.jiph.2023.11.003_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijantimicag.2016.09.014","article-title":"Synergistic combinations of polymyxins","volume":"48","author":"Lenhard","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2023.11.003_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.998671","article-title":"Discerning the role of polymyxin B nonapeptide in restoring the antibacterial activity of azithromycin against antibiotic-resistant Escherichia coli","volume":"13","author":"Al-Marzooq","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiph.2023.11.003_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10096-011-1360-5","article-title":"Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates","volume":"31","author":"Samonis","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiph.2023.11.003_bib22","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/jac\/dkv135","article-title":"Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two \u2018old\u2019 antibiotics\u2014polymyxin B and chloramphenicol","volume":"70","author":"Abdul Rahim","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib23","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/AAC.03639-14","article-title":"In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae","volume":"59","author":"Lim","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02319-16","article-title":"Nephrotoxicity of polymyxins: is there any difference between colistimethate and polymyxin B","volume":"61","author":"Zavascki","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jiph.2023.11.003_bib26","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.3390\/ijms24108662","article-title":"Boosting the antibacterial activity of azithromycin on multidrug-resistant Escherichia coli by efflux pump inhibition coupled with outer membrane permeabilization induced by phenylalanine-arginine \u03b2-naphthylamide","volume":"24","author":"Al-Marzooq","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiph.2023.11.003_bib27","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.3168\/jds.2020-18591","article-title":"Effect of milk bactofugation on the counts and diversity of thermoduric bacteria","volume":"103","author":"Ribeiro-J\u00fanior","year":"2020","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.jiph.2023.11.003_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133654","article-title":"Molecular analysis of antibiotic resistance determinants and plasmids in malaysian isolates of multidrug resistant Klebsiella pneumoniae","volume":"10","author":"Al-Marzooq","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2023.11.003_bib29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jac\/dkp498","article-title":"Development of a set of multiplex PCR assays for the detection of genes encoding important \u03b2-lactamases in Enterobacteriaceae","volume":"65","author":"Dallenne","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","article-title":"Multiplex PCR for detection of acquired carbapenemase genes","volume":"70","author":"Poirel","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiph.2023.11.003_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3036143","article-title":"Genomic characterization of MDR Escherichia coli harboring blaOXA-48 on the IncL\/M-type plasmid isolated from blood stream infection","volume":"2018","author":"Alousi","year":"2018","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jiph.2023.11.003_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jac\/dki412","article-title":"Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases","volume":"57","author":"Woodford","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib33","unstructured":"CLSI. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI guideline M100Performance Standards for Antimicrobial Susceptibility Testing 2023."},{"key":"10.1016\/j.jiph.2023.11.003_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277946","article-title":"Elucidating the effect of iron acquisition systems in Klebsiella pneumoniae on susceptibility to the novel siderophore-cephalosporin cefiderocol","volume":"17","author":"Daoud","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2023.11.003_bib35","first-page":"265","article-title":"Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa isolated from patients in Tehran, Iran","volume":"10","author":"Saderi","year":"2015","journal-title":"Iran J Pathol"},{"key":"10.1016\/j.jiph.2023.11.003_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00115-20","article-title":"New \u03b2-Lactam\u2013\u03b2-Lactamase inhibitor combinations","volume":"34","author":"Yahav","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiph.2023.11.003_bib37","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1021\/acs.jmedchem.7b00407","article-title":"Dipicolinic acid derivatives as inhibitors of New Delhi metallo-\u03b2-lactamase-1","volume":"60","author":"Chen","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.jiph.2023.11.003_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.823394","article-title":"Antibacterial activity of small molecules which eradicate methicillin-resistant Staphylococcus aureus persisters","volume":"13","author":"Hamad","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiph.2023.11.003_bib39","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s40121-021-00542-3","article-title":"Ceftazidime\u2013avibactam-based versus tigecycline-based regimen for the treatment of carbapenem-resistant Klebsiella pneumoniae-induced pneumonia in critically Ill patients","volume":"10","author":"Shi","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jiph.2023.11.003_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/microorganisms7100461","article-title":"Global burden of colistin-resistant bacteria: mobilized Colistin Resistance Genes Study (1980\u20132018)","volume":"7","author":"Elbediwi","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.jiph.2023.11.003_bib41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijantimicag.2014.12.013","article-title":"Emergence of Klebsiella pneumoniae producing dual carbapenemases (NDM-1 and OXA-232) and 16S rRNA methylase (armA) isolated from a Malaysian patient returning from India","volume":"45","author":"Al-Marzooq","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2023.11.003_bib42","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jgar.2020.06.009","article-title":"Molecular mechanisms and prevalence of colistin resistance of Klebsiella pneumoniae in the Middle East region: a review over the last 5 years","volume":"22","author":"Aris","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiph.2023.11.003_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijid.2022.04.034","article-title":"The first nationwide surveillance of carbapenem-resistant Enterobacterales in the United Arab Emirates \u2013 increased association of Klebsiella pneumoniae CC14 clone with Emirati patients","volume":"120","author":"Sonnevend","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiph.2023.11.003_bib44","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jgar.2022.11.013","article-title":"In vitro activity of cefiderocol against clinically important carbapenem non-susceptible Gram-negative bacteria from Saudi Arabia","volume":"32","author":"Alzayer","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiph.2023.11.003_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00084-22","article-title":"Emergence of high-level cefiderocol resistance in carbapenem-resistant Klebsiella pneumoniae from bloodstream infections in patients with hematologic malignancies in China","author":"Lan","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiph.2023.11.003_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01779-21","article-title":"In vitro evolution of cefiderocol resistance in an NDM-producing Klebsiella pneumoniae due to functional loss of CirA","volume":"9","author":"McElheny","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiph.2023.11.003_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/frabi.2023.1177954","article-title":"Prevalence and genetic characterization of clinically relevant extended-spectrum \u03b2-lactamase-producing Enterobacterales in the Gulf Cooperation Council countries","volume":"2","author":"Hadi","year":"2023","journal-title":"Front Antibiot"},{"key":"10.1016\/j.jiph.2023.11.003_bib48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.00096-12","article-title":"\u03b2-lactamase production in key Gram-negative pathogen isolates from the Arabian Peninsula","volume":"26","author":"Zowawi","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiph.2023.11.003_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131372","article-title":"Characterization of carbapenem-resistant Enterobacteriaceae with high rate of autochthonous transmission in the Arabian Peninsula","volume":"10","author":"Sonnevend","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2023.11.003_bib50","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1128\/AAC.02050-13","article-title":"Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf Cooperation Council: dominance of OXA-48 and NDM producers","volume":"58","author":"Zowawi","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib51","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.2147\/IDR.S378579","article-title":"Analysis of in vitro activity of cefiderocol against carbapenem-resistant Gram-negative bacilli by broth microdilution and disk diffusion method: a single-center study in Odisha, India","volume":"15","author":"Nayak","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jiph.2023.11.003_bib52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jgar.2021.04.019","article-title":"In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014\u20132018 studies in Italy","volume":"25","author":"Stracquadanio","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiph.2023.11.003_bib53","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/jac\/dkx049","article-title":"Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals","volume":"72","author":"Falagas","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib54","doi-asserted-by":"crossref","unstructured":"Johnston B.D., Thuras P., Porter S.B., Anacker M., VonBank B., Snippes Vagnone P., et al. Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region. Antimicrobial Agents and Chemotherapy n.d.;64:e00797\u201320. https:\/\/doi.org\/10.1128\/AAC.00797\u201320.","DOI":"10.1128\/AAC.00797-20"},{"key":"10.1016\/j.jiph.2023.11.003_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02171-20","article-title":"New perspectives on antimicrobial agents: cefiderocol","volume":"65","author":"McCreary","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib56","unstructured":"Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in Enterobacter cloacae Due to AmpC R2 Loop Deletion | Antimicrobial Agents and Chemotherapy n.d. \u3008https:\/\/journals.asm.org\/doi\/10.1128\/aac.00198\u201320\u3009 [Accessed July 14, 2023]."},{"key":"10.1016\/j.jiph.2023.11.003_bib57","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/cid\/ciaa355","article-title":"Clinical evolution of AmpC-mediated ceftazidime-avibactam and cefiderocol resistance in Enterobacter cloacae complex following exposure to cefepime","volume":"71","author":"Shields","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2023.11.003_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10096-022-04526-0","article-title":"Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa","volume":"42","author":"Sadek","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiph.2023.11.003_bib59","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciab511","article-title":"Rapid development of cefiderocol resistance in carbapenem-resistant Enterobacter cloacae during therapy is associated with heterogeneous mutations in the catecholate siderophore receptor cirA","volume":"74","author":"Klein","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2023.11.003_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100864","article-title":"Iron in infection and immunity","volume":"75","author":"Nairz","year":"2020","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.jiph.2023.11.003_bib61","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2023.11.003_bib62","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/AAC.01405-16","article-title":"Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa","volume":"60","author":"Ito","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2023.11.003_bib63","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/phar.1622","article-title":"The \u03b2-lactams strike back: ceftazidime-avibactam","volume":"35","author":"Zasowski","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiph.2023.11.003_bib64","first-page":"6","article-title":"Mono or combo? Exploring the role of combination antimicrobial therapies for invasive carbapenem-resistant Gram-negative infections","author":"Bullis","year":"2021","journal-title":"Contagion"},{"key":"10.1016\/j.jiph.2023.11.003_bib65","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.febslet.2011.04.054","article-title":"Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria","volume":"585","author":"Bolla","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jiph.2023.11.003_bib66","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10096-023-04671-0","article-title":"Extreme resistance to the novel siderophore-cephalosporin cefiderocol in an extensively drug-resistant Klebsiella pneumoniae strain causing fatal pneumonia with sepsis: genomic analysis and synergistic combinations for resistance reversal","volume":"42","author":"Daoud","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiph.2023.11.003_bib67","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/antibiotics12060980","article-title":"Inverse association between the existence of CRISPR\/Cas systems with antibiotic resistance, extended spectrum \u03b2-lactamase and carbapenemase production in multidrug, extensive drug and pandrug-resistant Klebsiella pneumoniae","volume":"12","author":"Jwair","year":"2023","journal-title":"Antibiotics"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034123003908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034123003908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:14:44Z","timestamp":1778829284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034123003908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":67,"alternative-id":["S1876034123003908"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2023.11.003","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High efficacy and enhanced synergistic activity of the novel siderophore-cephalosporin cefiderocol against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae from inpatients attending a single hospital in the United Arab Emirates","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2023.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}